| Source: |
| Type: |
| CD155 (PVR; poliovirus receptor; nectin-like protein 5/NECL-5) is an immunoglobulin-superfamily cell-adhesion molecule and immune-checkpoint ligand. It binds the inhibitory receptors TIGIT and CD96, as well as the activating receptor CD226/DNAM-1, on T cells and NK cells. CD155 is frequently overexpressed in cancer, where increased expression commonly promotes immune evasion, tumour-cell migration, invasion, proliferation, and poor prognosis. For cancer records, CD155/PVR ↑ is generally tumour-promoting, while CD155 blockade or reduction is usually considered beneficial; however, the specific receptor interaction should be recorded when known. Gene reference; Cancer review. |
| 6830- | EMD, | Anticancer activity of emodin is associated with downregulation of CD155 |
| - | vitro+vivo, | Melanoma, | B16-BL6 | - | in-vitro, | BC, | E0771 | - | in-vitro, | BC, | 4T1 |
| 9246- | ISO, IH, | Isorhamnetin inhibits migration and promotes apoptosis via modulation of oxidative stress, mitochondrial dysfunction, and the TIGIT/CD155 axis in 4T1 breast cancer cells |
| - | in-vitro, | BC, | 4T1 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1531 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid